Genetic Polymorphisms in Peripheral Arterial Disease, Role of Genomic Methodologies

Genomic and Personalized Medicine: V1-2

Volumn , Issue , 2008, Pages 773-780

  Dokun, Ayotunde O ^a   Annex, Brian H ^b  

^a Department of Medicine   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85137110353     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-369420-1.00064-0     Document Type: Chapter

References (46)

1. Biasucci L.M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., Rebuzzi A.G., Ciliberto G., Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation 1996, 94:874-877.
2. Boyd A.M. The natural course of arteriosclerosis of the lower extremities. Proc R Soc Med 1962, 55:591-593.
3. Christman S.K., Ahijevych K., Buckworth J. Exercise training and smoking cessation as the cornerstones of managing claudication. J Cardiovasc Nurs 2001, 15:64-77.
4. Conley P.B., Delaney S.M. Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 2003, 10:333-338.
5. Coughlin S.R. Thrombin signalling and protease-activated receptors. Nature 2000, 407:258-264.
6. Cronenwett J.L., Warner K.G., Zelenock G.B., Whitehouse W.M., Graham L.M., Lindenauer M., Stanley J.C. Intermittent claudication. Current results of nonoperative management. Arch Surg 1984, 119:430-436.
7. Dai Q., Huang J., Klitzman B., Dong C., Goldschmidt-Clermont P.J., March K.L., Rokovich J., Johnstone B., Rebar E.J., Spratt S.K., et al. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia. Circulation 2004, 110:2467-2475.
8. Darius H., Pittrow D., Haberl R., Trampisch H.J., Schuster A., Lange S., Tepohl H.G., Allenberg J.R., Diehm C. Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross-sectional study of 6880 primary care patients. Eur J Clin Invest 2003, 33:751-757.
9. Dawson D.L., Cutler B.S., Hiatt W.R., Hobson R.W., Martin J.D., Bortey E.B., Forbes W.P., Strandness D.E. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000, 109:523-530.
10. Flex A., Gaetani E., Pola R., Santoliquido A., Aloi F., Papaleo P., Dal Lago A., Pola E., Serricchio M., Tondi P., et al. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 2002, 24:264-268.
11. Fontana P., Dupont A., Gandrille S., Bachelot-Loza C., Reny J.L., Aiach M., Gaussem P. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation 2003, 108:989-995.
12. Fontana P., Gaussem P., Aiach M., Fiessinger J.N., Emmerich J., Reny J.L. P2Y12 H2 haplotype is associated with peripheral arterial disease: A case-control study. Circulation 2003, 108:2971-2973.
13. Fowkes F.G. Peripheral vascular disease: A public health perspective. J Public Health Med 1990, 12:152-159.
14. Fowkes F.G., Connor J.M., Smith F.B., Wood J., Donnan P.T., Lowe G.D. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 1992, 339:693-696.
15. Fukino K., Sata M., Seko Y., Hirata Y., Nagai R. Genetic background influences therapeutic effectiveness of VEGF. Biochem Biophys Res Commun 2003, 310:143-147.
16. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001, 86:222-232.
17. Gardner A.W., Katzel L.I., Sorkin J.D., Killewich L.A., Ryan A., Flinn W.R., Goldberg A.P. Improved functional outcomes following exercise rehabilitation in patients with intermittent claudication. J Gerontol A Biol Sci Med Sci 2000, 55:M570-mM577.
18. Gerhard M., Baum P., Raby K.E. Peripheral arterial-vascular disease in women: Prevalence, prognosis, and treatment. Cardiology 1995, 86:349-355.
19. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H., Sheahan R.G., Israelsson B., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277:1775-1781.
20. Gudmundsson G., Matthiasson S.E., Arason H., Johannsson H., Runarsson F., Bjarnason H., Helgadottir K., Thorisdottir S., Ingadottir G., Lindpaintner K., et al. Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31. Am J Hum Genet 2002, 70:586-592.
21. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
22. Hiatt W.R., Hoag S., Hamman R.F. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The Diabetes Study. Circulation 1995, 91:1472-1479.
23. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., Krook S.H., Hunninghake D.B., Comerota A.J., Walsh M.E., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
24. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., Hiratzka L.F., Murphy W.R., Olin J.W., Puschett J.B., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic) a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463-e654.
25. Imparato A.M., Kim G.E., Davidson T., Crowley J.G. Intermittent claudication: Its natural course. Surgery 1975, 78:795-799.
26. Jones W.S., Annex B.H. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Curr Opin Cardiol 2007, 22:458-463.
27. Kannel W.B., McGee D.L. Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 1985, 33:13-18.
28. Kullo I.J., Bailey K.R., Kardia S.L., Mosley T.H., Boerwinkle E., Turner S.T. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med 2003, 8:237-242.
29. Leng G.C., Fowler B., Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000, 63. CD000990.
30. Li Y., Hazarika S., Xie D., Pippen A.M., Kontos C.D., Annex B.H. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes 2007, 56:656-665.
31. Liu P.Q., Rebar E.J., Zhang L., Liu Q., Jamieson A.C., Liang Y., Qi H., Li P.X., Chen B., Mendel M.C., et al. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem 2001, 276:11323-11334.
32. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Celic L., Criqui M.H., Chan C., Martin G.J., Schneider J., Pearce W.H., et al. The ankle brachial index is associated with leg function and physical activity: The Walking and Leg Circulation Study. Ann Intern Med 2002, 136:873-883.
33. Milei J., Parodi J.C., Fernandez Alonso G., Barone A., Beigelman R., Ferreira L.M., Arrigoni G., Matturri L. Carotid atherosclerosis. Immunocytochemical analysis of the vascular and cellular composition in endarterectomies. Cardiologia 1996, 41:535-542.
34. Monsalve M.V., Robinson D., Woolcock N.E., Powell J.T., Greenhalgh R.M., Humphries S.E. Within-individual variation in serum cholesterol levels: Association with DNA polymorphisms at the apolipoprotein B and AI-CIII-AIV loci in patients with peripheral arterial disease. Clin Genet 1991, 39:260-273.
35. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., Powe N.R., Siscovick D. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 1999, 19:538-545.
36. Ouriel K. Peripheral arterial disease. Lancet 2001, 358:1257-1264.
37. Peters L.L., Robledo R.F., Bult C.J., Churchill G.A., Paigen B.J., Svenson K.L. The mouse as a model for human biology: A resource guide for complex trait analysis. Nat Rev Genet 2007, 8:58-69.
38. Rebar E.J., Huang Y., Hickey R., Nath A.K., Meoli D., Nath S., Chen B., Xu L., Liang Y., Jamieson A.C., et al. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 2002, 8:1427-1432.
39. Reny J.L., Alhenc-Gelas M., Fontana P., Bissery A., Julia P.L., Fiessinger J.N., Aiach M., Emmerich J. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: Results of a case-control study. J Thromb Haemost 2004, 2:1334-1340.
40. Resnick H.E., Rodriguez B., Havlik R., Ferrucci L., Foley D., Curb J.D., Harris T.B. Apo E genotype, diabetes, and peripheral arterial disease in older men: The Honolulu Asia-aging study. Genet Epidemiol 2000, 19:52-63.
41. Scholz D., Ziegelhoeffer T., Helisch A., Wagner S., Friedrich C., Podzuweit T., Schaper W. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002, 34:775-787.
42. Sheehan S.M., Tsaih S., King B.L., Stanton C., Churchill G.A., Paigen B., Dipetrillo K.J. Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice. Am J Physiol Renal Physiol 2007.
43. Wade C.M., Kulbokas E.J., Kirby A.W., Zody M.C., Mullikin J.C., Lander E.S., Lindblad-Toh K., Daly M.J. The mosaic structure of variation in the laboratory mouse genome. Nature 2002, 420:574-578.
44. Wang X., Korstanje R., Higgins D., Paigen B. Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 2004, 14:1767-1772.
45. Xie D., Li Y., Reed E.A., Odronic S.I., Kontos C.D., Annex B.H. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia. J Vasc Surg 2006, 44:166-175.
46. Yee K.O., Ikari Y., Schwartz S.M. An update of the Grutzbalg hypothesis: The role of thrombosis and coagulation in atherosclerotic progression. Thromb Haemost 2001, 85:207-217.